Early ivermectin does not reduce hospital admission in COVID-19
Apr 04, 2022
Also, no decrease was seen in prolonged emergency department visits for patients with COVID-19 symptoms for up to seven days and at least one risk factor for progression.
Poll: Most older adults want to age in place
Apr 15, 2022
The authors urge investing in home improvements to ensure future independence.
Free COVID-19 tests, treatments for uninsured Americans cut for lack of funding
Mar 23, 2022
The program reimburses hospitals, clinics, doctors and other service providers for COVID-19 care for uninsured people.
Rates of COVID-19, severe illness lower with BNT162b2 booster dose
Dec 09, 2021
A second study shows a reduction in the rate of death due to COVID-19 with a booster dose of BNT162b2 (Pfizer–BioNTech).
Itepekimab bests placebo for moderate-to-severe asthma
Oct 28, 2021
The incidence of events indicating a loss of asthma control was lower with itepekimab monotherapy in a phase 2, proof-of-concept trial.
New-onset cardiovascular complications common after stroke
Mar 31, 2022
The odds of five-year all-cause mortality were up for stroke patients with acute coronary syndrome, atrial fibrillation/flutter, heart failure or severe ventricular arrhythmias.
COVID-19 vaccine coverage in U.S. highest among those 65 and older
Jun 22, 2021
COVID-19 vaccine coverage is 80% among those aged 65 years and older, whereas 34% of those aged 18 to 39 years report having received a COVID-19 vaccine, according to two studies published in the June...
U.S. nursing home deaths rise as delta spreads
Oct 04, 2021
The numbers of nursing home deaths are still down significantly from their peak in late 2020, but the 1,800 residents and staff who died in August from the virus was the highest number in six months.
4.4 million Americans have gotten updated COVID-19 boosters
Sep 23, 2022
Public health officials expect the demand for the new booster to surge in the next few weeks.
Cerebral venous sinus rhrombosis rate up after Ad26.COV2.S shot
Nov 01, 2021
The postvaccination CVST rate was 5.1-fold higher among women compared with the pre-COVID-19 pandemic rate. Ad26.COV2.S is the Johnson & Johnson vaccine.